David Rusnak of BioAgilytix offers his expert opinion in this Virtual Podium presentation.Cell-based assays are a key component of the creation of new medicine, from early target and drug discover efforts through clinical trial and manufacturing support. Complex biochemical processes in the body can often be investigated and understood in cell-based model systems.
David has over twenty years of experience in government and industry at the National Institute of Environmental Health Sciences (NIEHS) and GlaxoSmithKline. He has experience in cell-based and immunoassays, specializing in assay development and automation.
So what system would be the most advantageous model for your project?